Welcome to our dedicated page for Bleichroeder Acquisition II news (Ticker: PSQL), a resource for investors and traders seeking the latest updates and insights on Bleichroeder Acquisition II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bleichroeder Acquisition II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bleichroeder Acquisition II's position in the market.
Pasqal (Nasdaq: PSQL) announced the nine-member Board of Directors of Pasqal Holding SA, formed after its business combination with Bleichroeder Acquisition Corp. II. The combined company’s ordinary shares are expected to start trading on Nasdaq under the ticker PSQL on August 28, 2026.
The Board is chaired in a non-executive capacity by co-founder and 2022 Physics Nobel laureate Alain Aspect. Other directors include CEO Wasiq Bokhari, Michel Combes as Lead Independent Director, and committee chairs Jean Raby (Audit), Andrew Gundlach (Compensation), and Barbara Dalibard (Nominating and Corporate Governance). Pasqal stated that a majority of the Board is independent under SEC and Nasdaq rules.
Pasqal Holding SA (Nasdaq: PSQL) and Bleichroeder Acquisition Corp. II (NASDAQ: BBCQ) have completed their previously announced business combination, following Bleichroeder shareholder approval on August 25, 2026. After a series of mergers, the surviving entity is Pasqal Holding SA, which will continue operating under the Pasqal name.
Pasqal’s ordinary shares and warrants are expected to begin trading on Nasdaq on August 28, 2026 under ticker symbols “PSQL” and “PSQLW”, while Bleichroeder’s Class A shares, warrants and units will cease trading. The transaction provides approximately $360 million of cash available at closing to accelerate deployment of Pasqal’s neutral-atom quantum systems, advance its roadmap toward fault-tolerant quantum computing, broaden cloud and software access, integrate with classical high-performance computing and scale global commercial operations.
Pasqal starts public life with seven quantum processing units deployed and three in production, supporting more than 25 commercial and research applications across multiple industries via a globally accessible cloud-based fleet.